Clinical Trial Update: Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update describing a Phase 1/2 study of liothyronine in combination with the BIT regimen for medulloblastoma, with or without minimal residual dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medulloblastoma

Drugs mentioned

• Liothyronine (liothyronine)

Snippet

Sponsor: Sabine Mueller, MD, PhD | Conditions: Medulloblastoma, Medulloblastoma, Childhood | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING